MOACM
SAGE

Mutual of America Capital Management’s Sage Therapeutics SAGE Stock Holding History

Mutual of America Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,746
Closed -$753K – 1638
2022
Q1 		$753K Sell
22,746
-987
-4% -$37.1K 0.01% 1068
2021
Q4 		$1.01M Sell
23,733
-221
-0.9% -$9.25K 0.01% 1059
2021
Q3 		$1.06M Sell
23,954
-2,101
-8% -$96.4K 0.01% 1067
2021
Q2 		$1.48M Sell
26,055
-1,180
-4% -$83.4K 0.01% 1045
2021
Q1 		$2.04M Sell
27,235
-1,456
-5% -$119K 0.02% 958
2020
Q4 		$2.48M Sell
28,691
-665
-2% -$49K 0.03% 814
2020
Q3 		$1.79M Sell
29,356
-4,680
-14% -$237K 0.02% 872
2020
Q2 		$1.42M Buy
34,036
+10,420
+44% +$378K 0.02% 960
2020
Q1 		$678K Buy
23,616
+39
+0.2% +$2.26K 0.01% 1052
2019
Q4 		$1.7M Buy
23,577
+10,254
+77% +$1.26M 0.02% 975
2019
Q3 		$1.87M Sell
13,323
-2,810
-17% -$470K 0.03% 890
2019
Q2 		$2.95M Buy
16,133
+10
+0.1% +$1.71K 0.04% 691
2019
Q1 		$2.56M Buy
16,123
+287
+2% +$41.6K 0.04% 751
2018
Q4 		$1.52M Hold
15,836
– – 0.03% 926
2018
Q3 		$2.24M Sell
15,836
-9,214
-37% -$1.42M 0.03% 850
2018
Q2 		$3.92M Sell
25,050
-10,165
-29% -$1.6M 0.06% 528
2018
Q1 		$5.67M Sell
35,215
-150
-0.4% -$25.5K 0.09% 310
2017
Q4 		$5.83M Sell
35,365
-1,981
-5% -$192K 0.09% 316
2017
Q3 		$2.33M Buy
37,346
+8,600
+30% +$675K 0.04% 777
2017
Q2 		$2.29M Buy
28,746
+27,696
+2,638% +$2M 0.04% 763
2017
Q1 		$75K Buy
+1,050
New +$61.5K ﹤0.01% 1168

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Mutual of America Capital Management's SAGE Position: Q2 2022 in Review

Mutual of America Capital Management sold out of Sage Therapeutics (SAGE) in Q2 2022, closing a stake of 22,746 shares — an estimated $753K sold.

Mutual of America Capital Management first reported a position in SAGE in Q1 2017 and held it in 21 quarters. The position peaked at $5.83M in Q4 2017. 210 funds tracked by Wall St. Rank hold SAGE as of Q2 2022.

  • Mutual of America Capital Management reported no remaining Sage Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 22,746 Sage Therapeutics shares in Q2 2022, an estimated $753K.
  • Mutual of America Capital Management first reported a position in Sage Therapeutics in Q1 2017 and held it in 21 quarters.
  • Mutual of America Capital Management's Sage Therapeutics position peaked at $5.83M in Q4 2017.
  • 210 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2022.

Based on Mutual of America Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.